Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.
Our previous studies have shown that neonatal exposure to lipopolysaccharide (LPS) resulted in motor dysfunction and dopaminergic neuronal injury in the juvenile rat brain. To further examine whether neonatal LPS exposure has persisting effects in adult rats, motor behaviors were examined from postnatal day 7 (P7) to P70 and brain injury was determined in P70 rats following an intracerebral injection of LPS (1 mg/kg) in P5 Sprague-Dawley male rats. Although neonatal LPS exposure resulted in hyperactivity in locomotion and stereotyped tasks, and other disturbances of motor behaviors, the impaired motor functions were spontaneously recovered by P70. On the other hand, neonatal LPS-induced injury to the dopaminergic system such as the loss of dendrites and reduced tyrosine hydroxylase immunoreactivity in the substantia nigra persisted in P70 rats. Neonatal LPS exposure also resulted in sustained inflammatory responses in the P70 rat brain, as indicated by an increased number of activated microglia and elevation of interleukin-1β and interleukin-6 content in the rat brain. In addition, when challenged with methamphetamine (METH, 0.5 mg/kg) subcutaneously, rats with neonatal LPS exposure had significantly increased responses in METH-induced locomotion and stereotypy behaviors as compared to those without LPS exposure. These results indicate that although neonatal LPS-induced neurobehavioral impairment is spontaneously recoverable, the LPS exposure-induced persistent injury to the dopaminergic system and the chronic inflammation may represent the existence of silent neurotoxicity. Our data further suggest that the compromised dendritic mitochondrial function might contribute, at least partially, to the silent neurotoxicity.
Fan
Lir-Wan
LW
Department of Pediatrics, Division of Newborn Medicine, University of Mississippi Medical Center, Jackson, MS 39216-4504, USA.
Tien
Lu-Tai
LT
Zheng
Baoying
B
Pang
Yi
Y
Lin
Rick C S
RC
Simpson
Kimberly L
KL
Ma
Tangeng
T
Rhodes
Philip G
PG
Cai
Zhengwei
Z
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000473:pathology*; D000697:Central Nervous System Stimulants; D016207:Cytokines / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D042967:Electron Transport Complex I / Q000378:metabolism; D005260:Female; D005552:Forelimb / Q000502:physiology; D007150:Immunohistochemistry; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008694:Methamphetamine; D009043:Motor Activity / Q000187:drug effects; D009048:Motor Skills / Q000502:physiology; D009474:Neurons / Q000473:pathology*; D020258:Neurotoxicity Syndromes / Q000473:pathology*; D010812:Physical Stimulation; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D013239:Stereotyped Behavior / Q000187:drug effects; D014738:Vibrissae / Q000294:innervation / Q000502:physiology
D000697:Central Nervous System Stimulants; D016207:Cytokines; D008070:Lipopolysaccharides; D008694:Methamphetamine; D042967:Electron Transport Complex I; D004298:Dopamine